Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Cencora Community
NYSE:COR Community
1
Narratives
written by author
0
Comments
on narratives written by author
27
Fair Values set
on narratives written by author
Create a narrative
Cencora
Popular
Undervalued
Overvalued
Community Investing Ideas
Cencora
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Investments In RCA And OneOncology Will Expand Specialty Pharma Leadership And Global Reach
Key Takeaways Strategic acquisitions and investments expand leadership in specialty pharmaceuticals, enhancing revenue through new services and high-growth market reach. Efficiency advancements and customer-centric strategies improve profitability and strengthen relationships, supporting future revenue growth through retention and service expansion.
View narrative
US$297.49
FV
1.9% undervalued
intrinsic discount
7.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
COR
COR
Cencora
Your Fair Value
US$
Current Price
US$291.97
36.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-3b
421b
2015
2018
2021
2024
2025
2027
2030
Revenue US$421.4b
Earnings US$1.9b
Advanced
Set Fair Value